Impact of [18F]-fluorodeoxyglucose ([18F]-FDG) imaging in sarcoidosis: unsuspected neurosarcoidosis discovered by [18F]-FDG PET and early metabolic response to corticosteroid therapy.

The British journal of radiology

Volumn 80, Issue 951, 2007, Pages

  Aide, N ^a   Benayoun, M ^a   Kerrou, K ^a   Khalil, A ^a   Cadranel, J ^a   Talbot, J N ^a  

^a Hopitaux de Paris   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; GLUCOCORTICOID; RADIOPHARMACEUTICAL AGENT;

ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; HYPOPHYSIS DISEASE; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; SARCOIDOSIS; SCINTISCANNING; TREATMENT OUTCOME;

FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOCORTICOIDS; HUMANS; MIDDLE AGED; PITUITARY DISEASES; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SARCOIDOSIS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 34447105913     PISSN: None     EISSN: 1748880X     Source Type: Journal    
DOI: 10.1259/bjr/33076108     Document Type: Article

References (0)